![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
FDA Advisory Panel Recommends Approval of Chelsea Therapeutics' NORTHERA(TM) (Droxidopa) for the Treatment of Symptomatic nOH
14 janv. 2014 17h09 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Jan. 14, 2014 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Announces First Patient Dosed in NORTHERA(TM) (droxidopa) Study 401 for the Treatment of Symptomatic nOH
09 déc. 2013 07h00 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Dec. 9, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that the first patient has been dosed in Study 401, a multi-center,...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Completes Public Offering of Common Stock
18 nov. 2013 10h32 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Nov. 18, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP), a development stage pharmaceutical company focused on the acquisition, development and...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Announces Pricing of Public Offering of Common Stock
13 nov. 2013 08h44 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Nov. 13, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP), a development stage pharmaceutical company focused on the acquisition, development and...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Announces Public Offering of Common Stock
12 nov. 2013 17h49 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Nov. 12, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP), a development stage pharmaceutical company focused on the acquisition, development and...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Reports Third Quarter 2013 Financial Results
05 nov. 2013 16h22 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Nov. 5, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the third quarter ended September 30, 2013.
"The third...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Announces FDA Advisory Committee to Review NORTHERA(TM) (droxidopa)
09 oct. 2013 16h01 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Oct. 9, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics to Present at BioCentury's 2013 Newsmakers in the Biotech Industry Conference
19 sept. 2013 07h00 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Sept. 19, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at BioCentury's 2013 Newsmakers in the Biotech Industry Conference at...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Announces FDA Acceptance of NORTHERA(TM) (droxidopa) NDA Resubmission
04 sept. 2013 16h01 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Sept. 4, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of...
![Chelsea Therapeutics Logo](/news-release/logo/213571/0/213571.jpg?lastModified=12%2F09%2F2016%2022%3A37%3A25&size=2)
Chelsea Therapeutics Announces Submission of Additional Information for NORTHERA(TM) (Droxidopa) NDA
14 août 2013 07h00 HE
|
Chelsea Therapeutics
CHARLOTTE, N.C., Aug. 14, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that it has submitted additional information to the U.S. Food and Drug...